Sign up to see all 5.
Sign up to see all 5.
No insider has filed a notice of proposed sale (Form 144) for Trinity Biotech PLC in the last 12 months.
There are not yet two fiscal years of reported share counts for Trinity Biotech PLC.
| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
HA
Hunter Associates Investment Management LLC
|
661.2K | 4.07% | +125.0K (+23.3%) | ≤2021 | 0.0% | |
|
Shares held by quarter
Peak holding661.2K (Q2'26)
Change over 8 quarters+301.4K
Share of the company4.070%
|
||||||
|
YA
Yorkville Advisors Global, LP
|
— | — | SOLD OUT | — | 0.0% | |
|
Shares held by quarter
|
||||||
22 more super investors behind a free account
See every manager holding Trinity Biotech PLC, how their position has changed, and how long they've held it.
Sign up free| Fund | Position value | Shares | % of company | % of the fund | As of |
|---|---|---|---|---|---|
|
FN
Fidelity Concord Street Trust
|
$11.7K | 16.6K | 0.10% | 0.00% | May 31, 2026 |
| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
JE
Joseph Edelman
5%+ holder
13D · 9.9%
|
3.42B | 21057.93% | — | — |
— | — |
|
This holder reports through Schedule 13D/G, not a quarterly 13F.
|
||||||
|
PC
Perceptive Credit Advisors LLC
5%+ holder
13D · 9.9%
|
3.42B | 21057.93% | — | — |
— | — |
|
This holder reports through Schedule 13D/G, not a quarterly 13F.
|
||||||
3 more holders behind a free account
See every insider and 5%+ holder of Trinity Biotech PLC.
Sign up freeLoading...